OUP user menu

Multidisciplinary treatment of desmoid tumours in Gardner’s syndrome due to a large interstitial deletion of chromosome 5q

M. Casper, E. Petek, W. Henn, M. Niewald, G. Schneider, V. Zimmer, F. Lammert, J. Raedle
DOI: http://dx.doi.org/10.1093/qjmed/hcu036 521-527 First published online: 19 February 2014

Abstract

Background and aims: Classic autosomal-dominant familial adenomatous polyposis (FAP) is clinically defined by the development of hundreds to thousands of colorectal adenomas beginning in childhood and adolescence. A variant of FAP characterized by polyposis in combination with osteomas or soft tissue tumours is called Gardner’s syndrome. FAP is caused by germline inactivation of the APC (adenomatous polyposis coli) tumour-suppressor gene located on the long arm of chromosome 5 (5q21–5q22). Cytogenetically visible deletions of chromosome 5q encompassing APC have very rarely been reported. Here, we aimed to phenotypically and genetically characterize a patient with a heterozygous 5q deletion resulting in Gardner’s syndrome.

Methods and results: A 26-year-old female patient with mild mental handicap and dysmorphic features due to a cytogenetically visible deletion on chromosome 5q (microscopically estimated region 5q14–5q23) presented at our tertiary referral centre because of mild adenomatous polyposis (<500 polyps). Twenty months after prophylactic proctocolectomy with definitive ileostomy, three rapidly growing desmoids were observed. Tumour-associated complications necessitated a multidisciplinary approach including medical treatment, surgery and radiation therapy. The characterization of the deletion by comparative genomic hybridization identified a large 5q deletion expanding over a 20-Mb region (5q21.3–5q23.3) including the APC gene.

Conclusion: Chromosome deletions must be suspected in patients presenting with FAP together with mental handicap and dysmorphic features. This case also impressively shows that FAP-associated desmoids need multimodal treatment taking into account the patient’s individual symptoms, disease progression and tumour location.

View Full Text
List of OpenAthens registered sites, including contact details.